Progyny, Inc. (PGNY)
Automate Your Wheel Strategy on PGNY
With Tiblio's Option Bot, you can configure your own wheel strategy including PGNY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PGNY
- Rev/Share 14.1894
- Book/Share 5.4639
- PB 3.8397
- Debt/Equity 0.0557
- CurrentRatio 2.394
- ROIC 0.0892
- MktCap 1798363640.0
- FreeCF/Share 2.2899
- PFCF 9.1855
- PE 34.169
- Debt/Assets 0.0356
- DivYield 0
- ROE 0.118
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 3
- P/B Score 2
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | PGNY | JMP Securities | Mkt Outperform | Market Perform | -- | -- | Sept. 19, 2024 |
News
Progyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building Solution
Published: June 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits. The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits.
Read More
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors
Published: May 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the addition of healthcare veteran Elizabeth Bierbower to its Board of Directors.
Read More
Progyny Appoints Two Renowned Women's Health Experts to Medical Advisory Board
Published: May 14, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the appointment of Morehouse School of Medicine's Regional Dean for Seattle and Puget Sound's Dr. Gloria Richard-Davis – a double-board certified physician in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, a fellow of the American College of Obstetricians & Gynecologists (FACOG), and a Menopause Society Certified Practitioner (MSCP) – and Columbia University's Dr. Whitney Booker – a double-board certified physician in Obstetrics and Gynecology and Maternal-Fetal Medicine – to its Medical Advisory Board. “As Progyny …
Read More
GDRX vs. PGNY: Which Stock Should Value Investors Buy Now?
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical Services sector might want to consider either GoodRx Holdings, Inc. (GDRX) or Progyny (PGNY). But which of these two stocks is more attractive to value investors?
Read More
Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report
Published: April 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building, will report its financial results for the quarterly period ended March 31, 2025, after the close of the market on Thursday, May 8, 2025.
Read More
Why Progyny (PGNY) is Poised to Beat Earnings Estimates Again
Published: April 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer
Published: April 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
The leadership additions support the company's continued ability to scale as it delivers the right care model for women's health and family building The leadership additions support the company's continued ability to scale as it delivers the right care model for women's health and family building
Read More
Progyny Expands Maternal Health Support with Addition of Doula Services
Published: March 31, 2025 by: GlobeNewsWire
Sentiment: Neutral
Available to employers and health plans, the in-person and virtual doula care services can close more care gaps and improve health outcomes Available to employers and health plans, the in-person and virtual doula care services can close more care gaps and improve health outcomes
Read More
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering
Published: March 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation
Read More
Progyny, Inc. to Participate in Upcoming Investor Conferences
Published: March 07, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced it expects to participate in several upcoming investor conferences. Progyny executives will participate in a fireside chat at the Leerink Partners Global Healthcare Conference in Miami, FL on Monday, March 10, 2025, at 11:20 a.m. Eastern Time. The executives will then be participating in meetings at the Barclays 27th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 11, 2025.
Read More
Progyny, Inc. (PGNY) Q4 2024 Earnings Call Transcript
Published: February 27, 2025 by: Seeking Alpha
Sentiment: Neutral
Progyny, Inc. (NASDAQ:PGNY ) Q4 2024 Earnings Conference Call February 27, 2025 4:45 PM ET Company Participants James Hart - Investor Relations Pete Anevski - Chief Executive Officer Mark Livingston - Chief Financial Officer Michael Sturmer - President Conference Call Participants Anne Samuel - JPMorgan Michael Cherny - Leerink Partners John Pinney - Canaccord Genuity Scott Schoenhaus - KeyBanc Jailendra Singh - Truist Securities Allen Lutz - Bank of America Sarah James - Cantor Constantine Davides - Citizens JMP Jenny Shen - BTIG Operator Good day, ladies and gentlemen. Welcome to the Progyny, Inc. Fourth Quarter Earnings Conference Call.
Read More
Progyny, Inc. Announces Fourth Quarter 2024 Results
Published: February 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
Reports Quarterly Revenue of $298.4 Million, Reflecting 10.6% GrowthGenerated $52.2 Million of Quarterly Operating Cash FlowIssues Financial Guidance for 2025, Reflecting Tenth Consecutive Year of Revenue Growth
Read More
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report
Published: February 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period and full year ended December 31, 2024, after the close of the market on Thursday, February 27, 2025. The company will host a conference call at 4:45 p.m.
Read More
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm
Published: February 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Progyny, Inc. (NASDAQ: PGNY) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.
Read More
About Progyny, Inc. (PGNY)
- IPO Date 2019-10-25
- Website https://www.progyny.com
- Industry Medical - Healthcare Information Services
- CEO Mr. Peter Anevski CPA
- Employees 675